Biol Reprod Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print December 26, 2003.
Biol Reprod 2003, 10.1095/biolreprod.103.022111
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
70/5/1263    most recent
biolreprod.103.022111v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huynh, K.
Right arrow Articles by Jones, M. E.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huynh, K.
Right arrow Articles by Jones, M. E.E.
Agricola
Right arrow Articles by Huynh, K.
Right arrow Articles by Jones, M. E.E.
BIOLOGY OF REPRODUCTION 70, 1263–1269 (2004)
DOI: 10.1095/biolreprod.103.022111
© 2004 by the Society for the Study of Reproduction, Inc.


Gamete Biology

Estrogen Is Not Directly Required for Oocyte Developmental Competence1

Kim Huynh3, Gayle Jones4, George Thouas4, Kara L. Britt5, Evan R. Simpson5, and Margaret E.E. Jones2,5

Department of Anatomy3 and Institute of Reproduction and Development,4 Monash University, Clayton, Victoria 3800, Australia Prince Henry's Institute of Medical Research,5 Clayton, Victoria 3168, Australia


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Oocyte maturation and ovulation require a coordinated interaction between gonadotrophs, steroid hormones, and growth factors. The extent to which estrogen is required in this process, however, remains unclear. To better understand the role of estrogen in maintaining developmental competence of mammalian oocytes, we studied the Aromatase knockout (ArKO) mouse, which has been genetically engineered to be incapable of synthesizing endogenous estrogen. Previous studies have established that ArKO female mice are anovulatory with ovaries that progressively degenerate, developing hemorrhagic cystic follicles. In young ArKO females, however, apparently healthy follicles and oocytes have been observed. We investigated if these oocytes could be induced to ovulate, then mature, fertilize, and develop in vitro. Following a standard superovulation protocol, ArKO oocytes did not ovulate. When recovered manually from the ovary, however, ArKO oocytes successfully progressed through in vitro maturation, fertilization, and development to the blastocyst stage at the same rate as wild-type and heterozygote littermates. Therefore, it appears that estrogen is not required for the production and growth of oocytes capable of maturation and complete preimplantation development but is required for continued follicle growth and feedback regulation of ovulation.

cumulus cells, estradiol, gamete biology, in vitro fertilization, oocyte development


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Mammalian oocyte growth, maturation, and ovulation, in partnership with folliculogenesis, is a coordinated process between gonadotrophs, growth factors, and sex steroids [1]. The capacity of follicles to produce estrogen is first apparent in the late preantral stage when they possess all the components of the two-cell, two-gonadotrophs model as previously described [2]. Estrogen is known to have an indirect but significant role in folliculogenesis and oogenesis, as estrogen regulates gonadotroph production and release due to its dual role as a positive and negative hypothalamus-pituitary-gonadal (HPG) regulator. Evidence also exists for a local role for estrogen within the ovary, including granulosa cell receptor expression and gap junction formation and survival (reviewed in [3]). A study performed by Goldenberg et al. [4] observed that estrogen production was greatest in the large follicles. Overes et al. [5] reported similar findings and suggested that estrogen production is limited in the smaller follicles, while it is the estrogen produced from the larger follicles that aids in follicle development. However, while it is believed that estrogen is an essential component of folliculogenesis, its exact role in oogenesis remains unclear.

The Aromatase knockout (ArKO) mouse, which lacks the capacity to synthesize endogenous estrogen, provides an opportunity to explore the nature of the role of estrogen in folliculogenesis and oocyte development. Female ArKO mice are infertile, primarily as a result of anovulation. Elevated serum FSH, LH, and testosterone levels correlate with a progressive degeneration of the ovary and its structures, including cystic and hemorrhagic follicles, a gradual loss of secondary and antral follicles, interstitial cell hyperplasia, and increased collagen deposition [6]. In 12- to 14-wk-old ArKO mice, however, follicles up to the large antral stage have been observed, containing apparently healthy oocytes. This therefore presents the question as to whether the young ArKO ovary is capable of responding to a protocol of superovulation induction and whether the observed oocytes are capable of sustaining fertilization and subsequent development. In this current study, we have characterized ArKO follicle and oocyte developmental competence using the techniques of in vitro maturation, fertilization, and culture to blastocyst. Our results demonstrate that 1) estrogen is indirectly required for ovulation as a negative regulator of gonadotroph production and 2) estrogen is not essential to maintain reproductive fitness of immature mammalian oocytes.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Animals

Littermate ArKO, wild-type (WT), and heterozygote (Het) mice were maintained on soy-free mouse chow (GlenForrest Stockfeeders, Western Australia). Animals were genotyped as previously described [7]. Two age groups were utilized for each experiment: 4 (prepubertal) and 7 (adult) wk of age. Two replicates of the first experiment (superovulation) were performed with 10 mice per group for each mouse genotype and age. Three replicates of the second experiment (in vitro maturation, fertilization, and culture) were carried out, 10 mice per genotype per age group. All experiments were conducted with appropriate Monash Medical Centre Animal Ethics Committee approval.

Superovulation Protocol

Mice were superovulated with an intraperitoneal (i.p.) injection of 5 IU eCG (5 IU/ml; Folligon, Intervet, Castle Hill, NSW, Australia) in 0.1 ml saline (0.9% NaCl; British Drug House, Kilsyth, VIC, Australia), followed 28 h later with an i.p. injection of 5 IU hCG (5 IU/ml; Chorulon, Intervet) in 0.1 ml saline (0.9% NaCl; British Drug House). Twelve hours after hCG injection, mice were killed by cervical dislocation. Both ovaries were excised and fixed immediately. Both oviducts were also excised and placed in 35-mm culture dishes (Falcon; Becton Dickinson Labware, Franklin Lakes, NJ) containing 2–4 ml prewarmed Hepes-buffered (Calbiochem, La Jolla, CA) potassium simplex optimized medium supplemented with amino acids (KSOMaa) handling medium [8] + 3 mg/ml BSA (Pentex Crystallized; Miles, Kankakee, IL), and opened with watchmakers forceps to release the cumulus-oocyte complexes (COCs), which were visualized using a stereoscopic microscope (Leica Wild 32; Heerbrugg, Switzerland) fitted with a warm stage at 37°C to reduce temperature changes. The number of COCs present in the oviducts of each mouse was recorded.

Once it had been established that ArKO ovaries did not respond to our superovulation regimen, the protocol was modified to remove the hCG injection. Mice were killed by cervical dislocation 48 h after the injection of eCG; the ovaries were excised and placed in 35-mm culture dishes containing 2–4 ml prewarmed Hepes-KSOMaa. The ovarian capsule was removed by blunt dissection and the ovaries were systematically punctured with a 29-gauge 0.33 x 12.7-mm ultrafine needle to release the immature COCs, which were visualized under a stereoscopic microscope fitted with a warm stage at 37°C.

Media and Culture Conditions

Potassium simplex optimized medium supplemented with amino acids (KSOMaa) was employed for handling, maturing, and culturing ArKO oocytes/zygotes [8]. Modified Tyrode 6 (MT6) culture medium was employed to capacitate sperm [9]. The media utilized for all experiments were filter-sterilized using 0.22-µm filters (Millepore Corporation, Bedford, MA). Experiments were repeated using charcoal-stripped, phenol-red-free media to ensure all potential sources of estrogenic-like activity were removed.

Oocytes/zygotes were cultured in groups of 10–15 per 20-µl microdrop of culture medium contained in 60-mm culture dishes (Falcon; Becton Dickinson Labware), which was overlaid with 7 ml light mineral oil (Sigma, St. Louis, MO) to prevent medium evaporation and to reduce pH fluctuations. All prepared culture dishes were equilibrated in a humidified atmosphere of 5% CO2 in air at 37°C for 4 h before use (Heraeus CO2 incubator; Radiometer Pacific, Copenhagen, Denmark). All cultures were performed under equivalent conditions.

Preparation of Sperm

Proven stud heterozygote male mice from the ArKO colony were killed by cervical dislocation and their epididymides were placed in a 35-mm culture dish containing 2–4 ml prewarmed Hepes-KSOMaa. An incision was made in the middle of the epididymis with a 19-gauge needle x 3/4 inch (Terumo, Elkton, MD). The epididymis was then placed in a loosely capped 5-ml tube containing equilibrated MT6 culture medium plus 3 mg/ ml BSA and incubated in a humidified atmosphere of 5% CO2 in air at 37°C for 2 h to allow the sperm to disperse and capacitate.

Oocyte Maturation Assessment

COCs were collected using a hand-drawn sterile glass pipette (Chase Instruments, Glen Falls, NY), briefly incubated in Hepes-KSOMaa containing 50 IU hyaluronidase (Sigma), and gently aspirated up and down to remove the cumulus cells. The oocytes were then rinsed in Hepes- KSOMaa to visualize the maturation status of the oocyte. The appearance of a nucleus within the cytoplasm of the oocyte in the absence of a polar body was used to indicate the germinal vesicle stage (prophase I) of development; the absence of a nucleus and a polar body identified germinal vesicle breakdown/metaphase I; and the presence of a polar body in the perivitelline space indicated metaphase II. Immature COCs were transferred to 60-mm culture dishes containing KSOMaa culture media supplemented with 10% fetal calf serum (Gibco BRL, Life Technologies Ltd., Auckland, New Zealand), 0.28% eCG, and 0.06% hCG and incubated as described above for 18 h. Maturation status was assessed at 6, 12, and 18 h.

Only the oocytes deemed mature were utilized for in vitro fertilization. Mature oocytes were rinsed in Hepes-KSOMaa and then MT6 before being transferred to 60-mm culture dishes containing microdrops of medium containing capacitated sperm. Spontaneous fertilization was allowed to progress for 2 h under the culture conditions described above. Oocytes were then rinsed and transferred to preequilibrated KSOMaa in 60-mm culture dishes and cultured for a further 4 h. Successful fertilization was assessed by the appearance of two pronuclei and the extrusion of a second polar body into the perivitelline space. Those oocytes failing to fertilize were removed from culture, leaving only zygotes in the culture dish. Zygotes were cultured for a further 4 days, at which time development to blastocyst was assessed and recorded.

Staining for Nuclear Chromatin

Approximately 30% of each type of oocyte recognized as immature, in vitro matured, and zygotes were randomly selected and stained in 2–3 ml Hoechst 33342 bisbenzimide (Sigma) overnight. Groups of 1–3 of these oocytes/zygotes were then transferred to a glass slide containing a minute drop of light mineral oil and covered with a 22- x 22-mm glass cover slip (Menzel-glaser; Saarbrockener, Braunschweigh, Germany). Chromatin was visualized using a fluorescence microscope fitted with an ultraviolet lamp and excitation fluorescence 460-nm blue filter (Leitz; Fluovert FU, Wetlar, Germany). The maturation/fertilization status of the oocytes was assessed based on the appearance of the chromatin within the germinal vesicle of the immature oocyte, the metaphase plate and polar body of the mature oocyte and within the pronuclei and second polar body of the fertilized oocytes.

Ovarian Histology

Ovaries were fixed in 10% formalin (pH 7.6) for 24 h at room temperature [10], then transferred to plastic cassettes (Tissue-Tek, Miles, Elkhart, IN) and processed manually by washing with saline followed by dehydration through graded ethanol steps to a 1-h incubation in heated (45°C) paraffin wax and embedding in paraffin. The paraffin blocks were immersed in mollifex (BDH Laboratory Supplies, Poole, England) for 1–2 min, and then placed on ice for 2–3 min before sectioning at 3 µm (Leica Wild 2030). Sections mounted on glass slides were dried overnight at 37°C. Sections were stained using a modified Masson Trichrome stain [11] and cover slipped using DPX (BDH Lab Supplies, Poole, England).

Statistics

Data were analyzed statistically by analysis of variance (ANOVA) followed by Tukey-Kramer post tests for multiple comparisons. Bartlett test was used to check for homogeneity of variances. A P value of less than 0.05 was considered to be biologically significant.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Response to Superovulation Induction

Cumulus-oocyte complexes (COCs) were not recovered from the oviducts of 4- or 7-wk-old ArKO mice following exogenous administration of eCG and hCG, whereas both WT and Het mice superovulated as expected with no difference in ovulation rate between genotypes. However there was a significant decrease in ovulation rates between the 4- and 7-wk-old WT and Het mice (P < 0.001) (Table 1). Interestingly, cumulus cells not containing oocytes were recovered from the oviducts of 4-wk-old (but not 7-wk-old) ArKO mice, indicating ovulation events involved in the breakdown of the follicle wall may still be present.


View this table:
[in this window]
[in a new window]
 
TABLE 1. The number of oocytes recovered per mouse following eCG-stimulation ± hCG.*

Ovarian Morphology

The ovarian morphology of superovulated 4-wk-old mice revealed that all stages of follicular development from primordial to antral stages were evident within the ovaries of all three genotypes. However, only WT and Het ovaries contained corpora lutea. Het and ArKO ovaries both presented with large cystic follicles, which is evidence of atresia. Oocytes within these atretic follicles were small, with pyknotic or absent nuclei, as reported previously in nonsuperovulated ArKO mice [6] (data not shown).

By 7 wk of age, conversely, there were pronounced differences in the ovarian morphology of superovulated mice. Wild-type ovaries, as expected, displayed an increased number of tightly packed follicles, ranging from primordial to preovulatory, together with corpora lutea. The Het ovaries exhibited a similar complement of developing follicles, but with an increase in the number of atretic follicles. The ArKO ovaries, in contrast, displayed aberrant morphology with large numbers of cystic follicles showing signs of atresia, containing shrunken, pyknotic, or anuclear oocytes, with only a few healthy-looking follicles. These follicles were loosely packed with an uneven, minimal, or absent granulosa cell layer (data not shown).

Retrieval of Oocytes

The number of immature oocytes harvested from 4-wk- old WT, Het, and ArKO following eCG stimulation did not differ significantly (P > 0.05), with an approximate average of 16 oocytes per mouse (Table 1). A noticeable difference between the ArKO, WT, and Het oocytes, however, was the presence or absence of surrounding cumulus cells. While WT and Het immature oocytes released from ovary perforations were all cumulus enclosed, the majority of 4-wk- old ArKO immature oocytes were deficient in cumulus cells. To compensate for this deficiency, cumulus cells were cultured together with immature oocytes in vitro to provide factors that may be beneficial to the oocyte during in vitro maturation. Oocytes retrieved from ArKO ovaries at 7 wk of age were not denuded, as observed for the 4-wk-old ArKO mice, but rather were enclosed within a typical cumulus complex.

Oocyte In Vitro Maturation, Fertilization, and Blastocyst Rates

Oocyte maturation rates were not significantly different between the three genotypes or across both age groups (P > 0.05), with almost 75% of the immature oocytes progressing to metaphase II in vitro (Table 2). Mature oocyte morphology from the three genotypes was also not different (Fig. 1). Chromatin staining confirmed the arrest of these oocytes at the second meiotic division, with chromatin staining clearly present in the oocyte and the polar body (data not shown).


View this table:
[in this window]
[in a new window]
 
TABLE 2. In vitro maturation, fertilization, and blastocyst development rates, expressed as percent of total.*



View larger version (112K):
[in this window]
[in a new window]
 
FIG. 1. The morphological appearance of in vitro-matured oocytes from eCG-stimulated mice. In vitro-matured oocytes appear identical between genotypes and age. Arrow indicates polar body. A) Four-week-old WT, (B) 4-wk-old Het, (C) 4-wk-old ArKO, (D) 7-wk-old WT, (E) 7-wk-old Het, (F) 7- wk-old ArKO. AF, original magnification x300

Only oocytes deemed mature (appearance of first polar body evident in perivitelline space; Fig. 1) were inseminated. Similar to in vitro maturation rates, in vitro fertilization rates did not differ between WT, Het, and ArKO oocytes (Table 2), with approximately 67% of the mature oocytes fertilizing.

Only those oocytes recognized as fertilized (presence of two pronuclei and a second polar body in the perivitelline space) were cultured to blastocysts. Blastocyst development rates for the WT, Het, and ArKO also did not differ significantly (Table 2), with approximately 65% of the zygotes developing to the blastocyst stage. WT, Het, and ArKO blastocyst morphology was also similar (Fig. 2).



View larger version (113K):
[in this window]
[in a new window]
 
FIG. 2. The morphological appearance of blastocysts cultured from eCG-stimulated mouse oocytes. All appear identical between genotypes and age. A) Four-week-old WT, (B) 4-wk-old Het, (C) 4-wk-old ArKO, (D) 7-wk-old WT, (E) 7-wk-old Het, (F) 7-wk-old ArKO. AF, original magnification x300

All in vitro maturation, fertilization, and blastocyst culture experiments repeated in charcoal-stripped, phenol-red- free media recorded equivalent results to those reported above (data not shown).


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The precise role estrogen plays in the reproductive system has been a source of contention. Although it has been known for some time that estrogen has a significant impact on female reproduction through its action on the HPG axis and its role as an intraovarian regulator of follicle development and function, the relative importance of these roles to folliculogenesis and oogenesis is poorly understood. Attempts to elucidate the role of estrogen in these reproductive events emerged from early studies employing surgical and pharmacological manipulations of estrogen; however, these studies were marred by the possibility of incomplete blockade of estrogen or failure to completely block estrogen signaling mechanisms via the estrogen receptor (ER) [12]. The generation of the ArKO mouse model has allowed for investigations to throw light on the role of estrogen in oocyte maturation and ovulation.

The current study demonstrates that the ovaries of 4- and 7-wk-old ArKO mice cannot be superovulated to produce COCs. However, when manually retrieved, oocyte in vitro maturation, fertilization, and blastocyst development rates did not differ between ArKO, WT, or Het mice or between the two age groups (4 and 7 wk old) examined, suggesting estrogen is not essential to maintain oocyte developmental competence.

The ArKO nonresponsiveness to a typical superovulation protocol is perhaps not surprising, given the chronically elevated levels of gonadotrophs reported in adult ArKO females [6, 13]. The ArKOs aged 12–14 wk in the Fisher et al. [13] study and the ArKOs aged 10–12 and 21– 23 wk and 1 yr in the Britt et al. [6] study all consistently displayed serum LH and FSH levels 2- to 10-fold higher than the WT at corresponding ages. Previous studies investigating the role of the ER signaling mechanism found that a dysfunctional HPG axis leads to overstimulation of LH production, which in turn results in hemorrhagic and cystic ovarian conditions (similar to that observed in this study and others) that are incapable of complete follicle development and growth [14, 15]. Adult {alpha}ERKO mice fail to spontaneously ovulate [14, 16], and this remains so following superovulation [14]. However, ovulatory capacity can be restored in the superovulated adult {alpha}ERKOs if they are first treated with gonadotroph antagonists that result in the restoration of gonadotroph and steroid levels to normal values in these mice [14]. Prepubertal {alpha}ERKOs have normal gonadotroph and steroid levels and are capable of ovulation following superovulation [14]. In contrast with the adult {alpha}ERKOs, adult ßERKOs can ovulate spontaneously, although at reduced rates, which are not improved by superovulation [17]. These mice have a normal HPG axis [18]; thus, estrogen is able to regulate the release of gonadotrophs in the ßERKO by acting on the ER{alpha} in the hypothalamus. It is likely that the actions of estrogen through the ERß receptor in the ovary is contributory to the process of ovulation but that the intraovarian role of estrogen in the process of follicle development to ovulation is much less important than its role as a feedback regulator of the HPG axis [17]. Observations of the ovulatory capacity in both ERKOs further support the hypothesis that a normal HPG axis is required for the maintenance of normal gonadotroph and steroid levels, which is essential to the process of ovulation. Further support is provided by observations in the {alpha}ßERKO model, where LH levels are elevated compared with other ERKOs [19, 20]. The {alpha}ßERKO also fails to ovulate spontaneously [19]. The {alpha}ßERKO ovarian morphology has also been reported to be significantly perturbed, exhibiting follicle transdifferentiation to structures resembling seminiferous tubules of the testis [19], a phenomenon also observed in ArKO ovaries [6]. The HPG axis in the {alpha}ßERKO has been reported to be dysfunctional, and the very high LH levels in this mouse indicate that the absence of estrogen action on both the hypothalamic ER{alpha} and the ovarian ERß leads to exacerbation of ovarian pathology. The recent report by Couse and colleagues [20] demonstrates that it is ER{alpha} that is essential to maintain proper function of the HPG axis.

Sexually immature ArKO females, however, were observed to partially respond to superovulation. Prepubertal (4-wk-old) ArKO oviducts did contain cumulus cells following eCG and hCG administration, suggesting these ovaries may have been responding to the exogenous gonadotrophs with the typical events involved in follicle wall breakdown to release the contents of the follicles. The absence of oocytes within these cumulus complexes indicates the oocytes within the final-stage tertiary follicles were atretic or their interaction with the intrafollicular cumulus cells was compromised in some way. There have been no reports on the endocrinology of prepubertal ArKOs to date; however, as the cyclic release of gonadotrophs does not occur until the onset of puberty, the prepubertal gonadotroph levels and thus the HPG axis in the ArKO is assumed to be normal; hence, elevated gonadotrophs are unlikely to be responsible for the attenuated response of 4-wk-old ArKO ovaries. Furthermore, the observation that cumulus cells, not COCs, were present in the oviducts of the 4-wk- old superovulated ArKOs suggests that some ovulatory response has occurred. That immature oocytes recovered from eCG-stimulated ovaries in the second experiment were deficient in cumulus cells suggests that there may be some pathology in the coupling of cumulus cells to the oocyte. Certainly, in states of low to nil estrogen, reminiscent of the ArKO mouse, gap junction formation has been reported to be compromised, and exogenous administration of 17ß-estradiol to ovariectomized or immature rats stimulated the formation of gap junctions [2123]. Therefore, it remained a possibility that superovulated prepubertal ArKOs did ovulate COCs; however, due to the tenuous relationship between the oocyte and its cumulus cells, the oocyte was retained in the bursa while the cumulus cells were picked up by the cilia on the fimbria and transported into the oviduct. Examination of ArKO bursa, however, demonstrated that oocytes were not being retained in this compartment (data not shown). Hence, the reason(s) behind the tenuous coupling of cumulus cells to the oocyte in the 4-wk-old superovulated ArKOs is unclear and remains to be clarified, but evidently, estrogen plays some indirect role in this event.

Surprisingly, inspection of ovaries from 4-wk-old superovulated ArKO mice did not reveal any CLs, as may be expected concomitant with cumulus cells being released into the oviduct. Transition of a follicle into a CL involves a multitude of remodeling events incorporating morphological, endocrinological, and biochemical changes. However, the vital importance of active, locally produced estrogen in the generation of healthy and fully functioning CLs has been demonstrated by others, e.g., Lund et al. [24]. Following administration of the aromatase inhibitor, arimidex, to proestrous ewes, Lund and colleagues reported that resultant CLs were smaller, contained fewer granulosa cells, were deficient in large steroidogenic cells, contained less progesterone than CLs from control animals, and were without the usual phagocyte influx into luteal tissues. The competency of the CLs from these ewes with attenuated estradiol biosynthesis was evidently significantly compromised. Similarly, given that ArKO mice are subject to lifelong estrogen deficiency, we postulate that the estrogen- regulated local events comprising the remodeling of tissue to form a CL are more severely compromised, and identifiable CLs are not generated.

Ovulation can be compared with an inflammatory response, in which cells of the immune system are recruited to the ovary and participate in the process of tissue remodeling. It has been established that estrogen contributes to regulating recruitment of these cells to the site of tissue remodeling involved in each ovulation event, particularly macrophage, neutrophilic granulocyte, and T lymphocyte populations [25, 26]. ER transcripts have been identified in mature peripheral T lymphocytes (reviewed in [27]), which have also been recovered from follicular fluid [28]. The tissue distribution of macrophages and neutrophils varies between preovulatory and ovulating follicles and is associated with increased numbers periovulation, suggesting they are actively participating in the ongoing tissue remodeling [25]. It is very likely, therefore, that the loss of endogenous estrogen in ArKO mice will have a significant effect on these populations of cells and their role in tissue remodeling concomitant with ovulation. Certainly, the chronic loss of estrogen in ArKO mice has been demonstrated to result in thymic regression and impaired thymocyte development [29]; however, the direct and indirect effects of this loss on follicle development in terms of cells of the immune system remain to be elucidated.

Treatment of 7-wk-old ArKOs with a gonadotroph antagonist in an attempt to restore normal circulating levels of gonadotrophs and androgens before superovulation treatment would be a valuable further experiment to explore the above hypothesis. In the event that ArKO mice fail to ovulate, the role of estrogen in the induction of LH- and FSH- receptor expression by the cumulus and granulosa cells should be examined. FSH and LH are key players in the processes of follicle recruitment and selection [30]. LH and FSH receptors are expressed by granulosa cells, and in response to the binding of estrogen to ERs, gonadotroph receptor numbers are significantly increased [31, 32]. A study determining whether LH and FSH receptors are present and in normal numbers in the follicles of the estrogen-deficient ArKO may reveal another potential cause for the failure of the ArKO to ovulate. If this is the case, it should also be noted that correcting LH- and FSH-receptor deficiency may not be as simple as supplying the mouse with exogenous estrogen. In the study carried out by Toda et al. [33], it was reported that administration of exogenous estrogen did not restore fertility to the ArKO and it was suggested that the ERs in these mice were unhealthy due to the presence of hemorrhagic and cystic follicles in ArKO ovaries. Thus, as well as examining ArKO follicles for functional LH and FSH receptors, the presence of functional ERs should also be investigated.

The present study provides further evidence in support of the hypothesis that estrogen is required to maintain normal circulating levels of gonadotrophs through its regulation via the HPG axis and that normal gonadotroph levels are required for complete follicle development and the process of ovulation. Prolonged exposure to very high levels of LH and androgens as a result of the failure of estrogen as a negative-feedback regulator of the HPG axis results in pathological ovarian morphology that deteriorates further with age. Therefore, estrogen indirectly maintains normal ovarian morphology that is required for complete follicle development and eventual ovulation.

The finding that ArKO oocytes were capable of maturation, fertilization, and development in similar numbers to WTs and Hets was somewhat surprising, as it has been reported that an androgen-dominated environment has a negative impact on oocyte maturation in vitro and subsequent embryo development [34]. In vitro maturation studies have yet to be performed in the ERKOs, so the relative importance of the action of estrogen on ER{alpha} and ERß to the process of oocyte maturation is not known. However, evidence from the ERKOs would suggest that functional estrogen signaling mechanisms are not required to confer maturational and developmental competence to the oocyte [17, 35]. The results in the present study support this hypothesis with the findings that exposure to estrogen at least up to the early antral stages of development is not essential for the oocyte to be developmentally competent. If there is indeed a need for estrogen for developmental competence, it is likely to be required at extremely low levels, as the experiments outlined in the present study were conducted in both complete and charcoal-stripped/phenol-red-free media under oil, which very rapidly depletes any available steroid in the culture medium [36, 37].

Comparative in vitro studies that complement this use of the ArKO mouse model have also investigated the consequences of estrogen depletion to follicle growth and oocyte maturation. Hu et al. [38] cultured mouse preantral follicles in vitro in the presence of Arimidex, an aromatase inhibitor. While Arimidex treatment impaired the fertilization rate of oocytes, there were no concomitant adverse effects on follicular development, in vitro ovulation rates, nor preimplantation embryo development.

The hypothesis that estrogen was essential for oocyte developmental competence was proposed due to the expression of mRNA for both estrogen receptors in mouse unfertilized oocytes [39] and COCs [39, 40] and in postimplantation mouse embryos from Days 8 to 18 of gestation [39] and human COCs and oocytes [41]. The estrogen-responsive finger protein, efp, demonstrated a similar expression pattern [40], indicating estrogen was active during these developmental windows. Data from those studies also suggested that the effects of estrogen may be direct via receptor-mediated mechanisms, or indirect, such as through the action of estrogen-regulated growth-promoting factors [39, 40]. Contrary to this supposition, however, the results from the current study demonstrate that estrogen action is not a requirement for oocyte developmental competency to the blastocyst stage. There are several reports in the literature regarding the role of estrogen and in particular its action via ERs on the development and implantation of preimplantation embryos [39, 42, 43]. These reported the presence of ER mRNA in the oocyte [39] and the presence of the ER in the nucleus of mouse blastocysts and in all blastocyst cell types [44] as well as the presence of ER protein in the blastocyst [43]. In the study of Hou et al. [44], it was also reported that embryos treated with estrogen in vitro have significantly higher implantation rates when transferred to foster mothers. It was thus suggested from these findings that estrogen action on ER at the blastocyst stage may aid in implantation of preimplantation embryos. Although immature oocytes from the ArKO are capable of maturation and complete embryo development to the implantation stage, it remains to be determined whether these blastocysts are capable of implanting and developing to normal offspring. Experiments involving the transfer of ArKO blastocysts to WT fosters would address this question.

In conclusion, the role of estrogen in ovulation appears to be to regulate cyclic gonadotroph release via its action on the ER{alpha}s in the hypothalamus. In doing so, estrogen maintains adequate ovarian conditions for growth and maturation of an ovulatory follicle and also aids in the initiation of recruitment, selection, and ovulation by triggering the secretion of the appropriate levels of gonadotrophs and stimulating adequate expression of FSH and LH receptors as well as ERs. Apparently, however, estrogen is not directly required for the production and growth of oocytes capable of maturation and complete preimplantation development. Whether the blastocysts developed from these oocytes are capable of complete development to live offspring when transferred to foster WTs remains to be elucidated.


    ACKNOWLEDGMENTS
 
The authors wish to thank Professor Jock Findlay for valuable discussion and Dr. Yoko Murata and Ms. Changhong Gong for their indispensable assistance with animals.


    FOOTNOTES
 
1 Supported in part by a National Health & Medical Research Council Project Grant (169010), a U.S. Public Health Service Grant (R37 AG- 08174), and a grant from the Victorian Breast Cancer Research Consortium, Inc. Back

2 Correspondence: Margaret Jones, PHIMR, Level 4, Block E, 246 Clayton Road, Clayton VIC 3168, Australia. FAX: 61 3 9594 6376; Margaret.Jones{at}phimr.monash.edu.au Back

Received: 11 August 2003.

First decision: 30 August 2003.

Accepted: 23 December 2003.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Findlay JK, Britt K, Kerr JB, O'Donnell L, Jones ME, Drummond AE, Simpson ER. The road to ovulation: the role of oestrogens. Reprod Fertil Dev 2001 13:1-4[CrossRef][Medline]
  2. Drummond AE, Findlay JK. The role of estrogen in folliculogenesis. Mol Cell Endocrinol 1999 151:57-64[CrossRef][Medline]
  3. Rosenfeld CS, Wagner JS, Roberts RM, Lubahn DB. Intraovarian actions of estrogen. Reproduction 2001 122:215-226[Abstract]
  4. Goldenberg RL, Vaitukaitis JL, Ross GT. Estrogen and follicle stimulation hormone interactions on follicle growth in rats. Endocrinology 1972 90:1492-1498[Medline]
  5. Overes HW, de Leeuw R, Kloosterboer HJ. Regulation of aromatase activity in FSH-primed rat granulosa cells in vitro by follicle-stimulating hormone and various amounts of human chorionic gonadotrophin. Hum Reprod 1992 7:191-196[Abstract/Free Full Text]
  6. Britt KL, Drummond AE, Cox V, Dyson M, Wreford N, Jones ME, Simpson ER, Findlay JK. An age-related ovarian phenotype in mice with targeted disruption of the Cyp 19 (aromatase) gene. Endocrinology 2000 141:2614-2623[Abstract/Free Full Text]
  7. Robertson K, O'Donnell L, Jones MEE, Meachem S, Boon WC, Fisher C, Graves KH, McLachlan RI, Simpson ER. Impairment of spermatogenesis in mice lacking the aromatase (cyp 19) gene (ArKO). Proc Natl Acad Sci U S A 1999 96:7986-7991[Abstract/Free Full Text]
  8. Elhassan YM, Wu G, Leanez AC, Tasca RJ, Watson AJ, Westhusin ME. Amino acid concentrations in fluids from the bovine oviduct and uterus and in KSOM-based culture media. Theriogenology 2001 55:1907-1918[CrossRef][Medline]
  9. Werner M, Chott A, Fabiano A, Battifora H. Effect of formalin tissue fixation and processing on immunohistochemistry. Am J Surg Pathol 2000 24:1016-1019[CrossRef][Medline]
  10. Whittingham DG. Culture of mouse ova. J Reprod Fertil Suppl 1971 14:7-21[Medline]
  11. Masson L. Some histological methods, Trichrome stainings and their preliminary findings. Bull Int Assoc Med 1929 12:75-90
  12. Wang XN, Greenwald GS. Synergistic effects of steroids with FSH on folliculogenesis, steroidogenesis and FSH- and hCG-receptors in hypophysectomized mice. J Reprod Fertil 1993 99:403-413[Abstract/Free Full Text]
  13. Fisher CR, Graves KH, Parlow AF, Simpson ER. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci U S A 1998 95:6965-6970[Abstract/Free Full Text]
  14. Schomberg DW, Couse JF, Mukherjee A, Lubahn DB, Sar M, Mayo KE, Korach KS. Targeted disruption of the estrogen receptor-alpha gene in female mice: characterization of ovarian responses and phenotype in the adult. Endocrinology 1999 140:2733-2744[Abstract/Free Full Text]
  15. Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr Rev 1999 20:358-417[Abstract/Free Full Text]
  16. Lubahn DB, Moyer JS, Golding TS, Couse JF, Korach KS, Smithies O. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A 1993 90:11162-11166[Abstract/Free Full Text]
  17. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler M, Sar M, Korach KS, Gustafsson JA, Smithies O. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A 1998 95:15677-15682[Abstract/Free Full Text]
  18. Curtis-Hewitt S, Korach K. Oestrogen receptor knockout mice: roles for oestrogen receptors {alpha} and ß in reproductive tissues. Reproduction 2003 125:143-149[Abstract]
  19. Couse JF, Curtis Hewitt S, Bunch DO, Sar M, Walker VR, Davis BJ, Korach KS. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. Science 1999 286:2328-2331[Abstract/Free Full Text]
  20. Couse JF, Yates MM, Walker VR, Korach KS. Characterisation of the hypothalamic-pituitary-gonadal axis in estrogen receptor (ER) null mice reveals hypergonadism and endocrine sex reversal in females lacking ER{alpha} but not ERß. Mol Endocrinol 2003 17:1039-1053[Abstract/Free Full Text]
  21. Wathes DC, Porter DG. Effect of uterine distension and oestrogen treatment on gap junction formation in the myometrium of the rat. J Reprod Fertil 1982 65:497-505[Abstract/Free Full Text]
  22. Mackenzie LW, Garfield RE. Effects of tamoxifen citrate and cycloheximide on estradiol induction of rat myometrial gap junctions. Can J Physiol Pharmacol 1986 64:703-706[Medline]
  23. Mackenzie LW, Garfield RE. Effects of 17 beta-estradiol on myometrial gap junctions and pregnancy in the rat. Can J Physiol Pharmacol 1986 64:462-466[Medline]
  24. Lund SA, Murdoch J, Van Kirk EA, Murdoch WJ. Mitogenic and antioxidant mechanisms of estradiol action in preovulatory ovine follicles: relevance to luteal function. Biol Reprod 1999 61:388-392[Abstract/Free Full Text]
  25. Brannstrom M, Mayrhofer G, Robertson S. Localization of leukocyte subsets in the rat ovary during the periovulatory period. Biol Reprod 1993 48:277-286[Abstract]
  26. Hellberg P, Thomsen P, Janson PO, Brannstrom M. Leukocyte supplementation increases the luteinizing hormone-induced ovulation rate in the in vitro-perfused rat ovary. Biol Reprod 1991 44:791-797[Abstract]
  27. Tanriverdi F, Silveira LFG, MaColl GS, Bouloux PMG. The hypothalamic-pituitary-gonadal axis, the immune function and autoimmunity. J Endocrinol 2003 176:293-304[Abstract]
  28. Hill JA, Barbieri RL, Anderson DJ. Detection of T8 (suppressor/cytotoxic) lymphocytes in human ovarian follicular fluid. Fertil Steril 1987 47:114-117[Medline]
  29. Li CL, Toda K, Saibara T, Zhang T, Ono M, Iwasaki S, Maeda T, Okada T, Hayashi Y, Enzan H, Shizuta Y, Onishi S. Estrogen deficiency results in enhanced Smoothened of the Hedgehog signaling in the thymus and affects thymocyte development.. Int Immunopharmacol 2002 2:823-833[CrossRef][Medline]
  30. Webb R, Campbell BK, Garverick HA, Gong JG, Gutierrez CG, Armstrong DG. Molecular mechanisms regulating follicular recruitment and selection. J Reprod Fertil Suppl 1999 54:33-48[Medline]
  31. Adashi EY. Endocrinology of the ovary. Hum Reprod 1994 9:815-827[Free Full Text]
  32. Richards JS, Kersey KA. Changes in theca and granulosa cell function in antral follicles developing during pregnancy in the rat: gonadotropin receptors, cyclic AMP and estradiol-17 beta. Biol Reprod 1979 21:1185-1201[Abstract]
  33. Toda K, Takeda K, Okada T, Akira S, Saibara T, Kaname T, Yamamura K, Onishi S, Shizuta Y. Targeted disruption of the aromatase P450 gene (Cyp 19) in mice and their ovarian and uterine responses to 17b- oestradiol. J Endocrinol 2001 170:99-111[Abstract]
  34. Anderiesz C, Trounson AO. The effect of testosterone on the maturation and developmental capacity of murine oocytes in vitro. Hum Reprod 1995 10:2377-2381[Abstract/Free Full Text]
  35. Couse JF, Bunch DO, Lindzey J, Schomberg DW, Korach KS. Prevention of the polycystic ovarian phenotype and characterization of ovulatory capacity in the estrogen receptor-alpha knockout mouse. Endocrinology 1999 140:5855-5865[Abstract/Free Full Text]
  36. Funahashi H, Cantley T, Day BN. Different hormonal requirements of pig oocyte-cumulus complexes during maturation in vitro. J Reprod Fertil 1994 101:159-165[Abstract/Free Full Text]
  37. Shimada M, Kawano N, Terada T. Delay of nuclear maturation and reduction in developmental competence of pig oocytes after mineral oil overlay of in vitro maturation media. Reproduction 2002 124:557-564[Abstract]
  38. Hu Y, Cortvrindt R, Smitz J. Effects of aromatase inhibition on in vitro follicle and oocyte development analysed by early preantral mouse follicle culture. Mol Reprod Dev 2002 61:549-559[CrossRef][Medline]
  39. Wu TC, Wang L, Wan YJ. Expression of estrogen receptor gene in mouse oocyte and during embryogenesis. Mol Reprod Dev 1992 33:407-412[CrossRef][Medline]
  40. Hiroi H, Momoeda M, Inoue S, Tsuchiya F, Matsumi H, Tsutsumi O, Muramatsu M, Taketani Y. Stage-specific expression of estrogen receptor subtypes and estrogen responsive finger protein in preimplantational mouse embryos. Endocr J 1999 46:153-158[Medline]
  41. Wu TC, Wang L, Wan YJ. Detection of estrogen receptor messenger ribonucleic acid in human oocytes and cumulus-oocyte complexes using reverse transcriptase-polymerase chain reaction. Fertil Steril 1993 59:54-59[Medline]
  42. Hou Q, Gorski J. Estrogen receptor and progesterone receptor genes are expressed differentially in mouse embryos during preimplantation development. Proc Natl Acad Sci U S A 1993 90:9460-9464[Abstract/Free Full Text]
  43. Paria BC, Das SK, Andrews GK, Dey SK. Expression of the epidermal growth factor receptor gene is regulated in mouse blastocysts during delayed implantation. Proc Natl Acad Sci U S A 1993 90:55-59[Abstract/Free Full Text]
  44. Hou Q, Paria BC, Mui C, Dey SK, Gorski J. Immunolocalization of estrogen receptor protein in the mouse blastocyst during normal and delayed implantation. Proc Natl Acad Sci U S A 1996 93:2376-2381[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Biol. Reprod.Home page
I. Segers, T. Adriaenssens, W. Coucke, R. Cortvrindt, and J. Smitz
Timing of Nuclear Maturation and Postovulatory Aging in Oocytes of In Vitro-Grown Mouse Follicles with or Without Oil Overlay
Biol Reprod, May 1, 2008; 78(5): 859 - 868.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. A. Murray, A. K.E. Swales, R. E. Smith, M. D. Molinek, S. G. Hillier, and N. Spears
Follicular growth and oocyte competence in the in vitro cultured mouse follicle: effects of gonadotrophins and steroids
Mol. Hum. Reprod., February 1, 2008; 14(2): 75 - 83.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Motola, M. Popliker, and A. Tsafriri
Are Steroids Obligatory Mediators of Luteinizing Hormone/Human Chorionic Gonadotropin-Triggered Resumption of Meiosis in Mammals?
Endocrinology, September 1, 2007; 148(9): 4458 - 4465.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
N. Kawano and M. Yoshida
Semen-Coagulating Protein, SVS2, in Mouse Seminal Plasma Controls Sperm Fertility
Biol Reprod, March 1, 2007; 76(3): 353 - 361.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. M. Kocabas, J. Crosby, P. J. Ross, H. H. Otu, Z. Beyhan, H. Can, W.-L. Tam, G. J. M. Rosa, R. G. Halgren, B. Lim, et al.
The transcriptome of human oocytes
PNAS, September 19, 2006; 103(38): 14027 - 14032.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. M. A. Emmen, J. F. Couse, S. A. Elmore, M. M. Yates, G. E. Kissling, and K. S. Korach
In Vitro Growth and Ovulation of Follicles from Ovaries of Estrogen Receptor (ER){alpha} and ER{beta} Null Mice Indicate a Role for ER{beta} in Follicular Maturation
Endocrinology, June 1, 2005; 146(6): 2817 - 2826.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
70/5/1263    most recent
biolreprod.103.022111v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huynh, K.
Right arrow Articles by Jones, M. E.E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huynh, K.
Right arrow Articles by Jones, M. E.E.
Agricola
Right arrow Articles by Huynh, K.
Right arrow Articles by Jones, M. E.E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS